Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APRE | AZN | AMGN | GILD | VRTX |
| Company | Aprea Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7900 | 177.67 | 344.38 | 125.85 | 462.17 |
| High | 0.7900 | 177.80 | 345.00 | 126.39 | 464.98 |
| Low | 0.7501 | 173.66 | 334.05 | 122.43 | 450.44 |
| Latest | 0.7651 | 175.25 | 335.47 | 123.08 | 454.05 |
| Change | -0.0147 | -2.64 | -6.19 | -2.37 | -4.94 |
| % Change | -1.89% | -1.48% | -1.81% | -1.89% | -1.08% |
| Volume | 31,472 | 1,142,414 | 2,417,958 | 3,883,651 | 1,048,155 |
| 20-Day Average Volume | 120,403 | 1,978,229 | 2,739,973 | 8,256,962 | 1,291,705 |
| Previous Close | 0.7798 | 177.89 | 341.66 | 125.45 | 458.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8023 | 181.78 | 341.27 | 128.77 | 442.39 |
| 20-Day Raw Stochastic | 38.28% | 7.42% | 35.77% | 9.42% | 75.89% |
| 20-Day Relative Strength | 47.03 | 40.58 | 46.29 | 39.38 | 55.39 |
| Weighted Alpha | -58.73 | +15.37 | +12.34 | +6.07 | +5.49 |
| Today's Opinion | 72% Sell | 72% Sell | 8% Sell | 72% Sell | 40% Buy |
| Previous Opinion | 72% Sell | 56% Sell | 24% Buy | 72% Sell | 40% Buy |
| Last Month's Opinion | 48% Sell | 24% Sell | 24% Sell | 24% Sell | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.98% since 06/11/26 | -3.98% since 06/11/26 | -5.32% since 06/11/26 | -2.38% since 06/11/26 | +1.94% since 06/11/26 |
| Low | 0.6500 on 06/12/26 | 173.70 on 06/18/26 | 334.05 on 06/18/26 | 122.43 on 06/18/26 | 439.50 on 06/15/26 |
| High | 0.7934 on 06/17/26 | 182.70 on 06/12/26 | 358.30 on 06/15/26 | 128.20 on 06/17/26 | 464.39 on 06/18/26 |
| 1-Month | |||||
| %Chg | -8.60% since 05/18/26 | -4.84% since 05/18/26 | +3.34% since 05/18/26 | -5.24% since 05/18/26 | +3.92% since 05/18/26 |
| Low | 0.6500 on 06/12/26 | 173.70 on 06/18/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 0.9700 on 05/26/26 | 191.50 on 05/21/26 | 358.46 on 06/11/26 | 137.20 on 05/29/26 | 464.39 on 06/18/26 |
| 3-Month | |||||
| %Chg | +5.66% since 03/18/26 | -7.11% since 03/18/26 | -4.62% since 03/18/26 | -13.03% since 03/18/26 | +0.47% since 03/18/26 |
| Low | 0.6000 on 03/30/26 | 173.70 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 1.1200 on 04/17/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 464.39 on 06/18/26 |
| 6-Month | |||||
| %Chg | -15.12% since 12/18/25 | -3.42% since 12/18/25 | +3.33% since 12/18/25 | +1.16% since 12/18/25 | +1.41% since 12/18/25 |
| Low | 0.5480 on 01/29/26 | 173.70 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 1.4900 on 01/30/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,656 | 275,891,008 | 184,396,640 | 155,754,944 | 116,493,952 |
| Shares Outstanding, K | 12,383 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 290,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -12,600,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -3,290,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 1.51 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 05/13/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/11/26 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.30 | 15.74 | 15.20 | 26.94 |